1. Non-Coding RNAs and Wnt/β-Catenin Signaling Pathway in Gastric Cancer: From EMT to Drug Resistance
   Bruno Takao Real Karia et al, 2021, Onco CrossRef
2. Targeting Wnt Signaling in Endometrial Cancer
   Iram Fatima et al, 2021, Cancers CrossRef
3. The interplay between microRNAs and Twist1 transcription factor: a systematic review
   Hashem Khanbabaei et al, 2016, Tumor Biology CrossRef
4. β-catenin inhibitors in cancer therapeutics: intricacies and way forward
   Arundhathi Dev et al, 2023, Bioengineered CrossRef
5. WNT/β-catenin signaling in urothelial carcinoma of bladder
   Minal Garg et al, 2019, World J Nephrol CrossRef
6. An updated review of the H19 lncRNA in human cancer: molecular mechanism and diagnostic and therapeutic importance
   Behnam Alipoor et al, 2020, Molecular Biology Reports CrossRef
7. MiR-26b-3p Promotes Intestinal Motility Disorder by Targeting FZD10 to Inhibit GSK3β/β-Catenin Signaling and Induce Enteric Glial Cell Apoptosis
   Yu Zhan et al, 2024, Molecular Neurobiology CrossRef
8. Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review
   Miguel Angel Chiurillo, 2015, World Journal of Experimental Medicine CrossRef
9. A regulatory loop containing miR-26a, GSK3β and C/EBPα regulates the osteogenesis of human adipose-derived mesenchymal stem cells
   Zi Wang et al, 2015, Scientific Reports CrossRef
10. GSK3 inhibitors CHIR99021 and 6-bromoindirubin-3′-oxime inhibit microRNA maturation in mouse embryonic stem cells
    Yongyan Wu et al, 2015, Scientific Reports CrossRef